IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.

Standard

IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. / Belloni, Laura; Allweiss, Lena; Guerrieri, Francesca; Pediconi, Natalia; Volz, Tassilo; Pollicino, Teresa; Petersen, Joerg; Raimondo, Giovanni; Dandri-Petersen, Maura; Levrero, Massimo.

In: J CLIN INVEST, Vol. 122, No. 2, 2, 2012, p. 529-537.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{cd16b458c0f44e3f9dde775fb6a638e4,
title = "IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.",
abstract = "HBV infection remains a leading cause of death worldwide. IFN-? inhibits viral replication in vitro and in vivo, and pegylated IFN-? is a commonly administered treatment for individuals infected with HBV. The HBV genome contains a typical IFN-stimulated response element (ISRE), but the molecular mechanisms by which IFN-? suppresses HBV replication have not been established in relevant experimental systems. Here, we show that IFN-? inhibits HBV replication by decreasing the transcription of pregenomic RNA (pgRNA) and subgenomic RNA from the HBV covalently closed circular DNA (cccDNA) minichromosome, both in cultured cells in which HBV is replicating and in mice whose livers have been repopulated with human hepatocytes and infected with HBV. Administration of IFN-? resulted in cccDNA-bound histone hypoacetylation as well as active recruitment to the cccDNA of transcriptional corepressors. IFN-? treatment also reduced binding of the STAT1 and STAT2 transcription factors to active cccDNA. The inhibitory activity of IFN-? was linked to the IRSE, as IRSE-mutant HBV transcribed less pgRNA and could not be repressed by IFN-? treatment. Our results identify a molecular mechanism whereby IFN-? mediates epigenetic repression of HBV cccDNA transcriptional activity, which may assist in the development of novel effective therapeutics.",
keywords = "Animals, Humans, Mice, Mice, Transgenic, Cell Culture Techniques, Mice, SCID, Virus Replication, *Transcription, Genetic, Chimerism, DNA, Circular/genetics/*metabolism, *Epigenesis, Genetic, Hepatitis B virus/*genetics/metabolism, Interferon-alpha/*metabolism, Animals, Humans, Mice, Mice, Transgenic, Cell Culture Techniques, Mice, SCID, Virus Replication, *Transcription, Genetic, Chimerism, DNA, Circular/genetics/*metabolism, *Epigenesis, Genetic, Hepatitis B virus/*genetics/metabolism, Interferon-alpha/*metabolism",
author = "Laura Belloni and Lena Allweiss and Francesca Guerrieri and Natalia Pediconi and Tassilo Volz and Teresa Pollicino and Joerg Petersen and Giovanni Raimondo and Maura Dandri-Petersen and Massimo Levrero",
year = "2012",
language = "English",
volume = "122",
pages = "529--537",
journal = "J CLIN INVEST",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

RIS

TY - JOUR

T1 - IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.

AU - Belloni, Laura

AU - Allweiss, Lena

AU - Guerrieri, Francesca

AU - Pediconi, Natalia

AU - Volz, Tassilo

AU - Pollicino, Teresa

AU - Petersen, Joerg

AU - Raimondo, Giovanni

AU - Dandri-Petersen, Maura

AU - Levrero, Massimo

PY - 2012

Y1 - 2012

N2 - HBV infection remains a leading cause of death worldwide. IFN-? inhibits viral replication in vitro and in vivo, and pegylated IFN-? is a commonly administered treatment for individuals infected with HBV. The HBV genome contains a typical IFN-stimulated response element (ISRE), but the molecular mechanisms by which IFN-? suppresses HBV replication have not been established in relevant experimental systems. Here, we show that IFN-? inhibits HBV replication by decreasing the transcription of pregenomic RNA (pgRNA) and subgenomic RNA from the HBV covalently closed circular DNA (cccDNA) minichromosome, both in cultured cells in which HBV is replicating and in mice whose livers have been repopulated with human hepatocytes and infected with HBV. Administration of IFN-? resulted in cccDNA-bound histone hypoacetylation as well as active recruitment to the cccDNA of transcriptional corepressors. IFN-? treatment also reduced binding of the STAT1 and STAT2 transcription factors to active cccDNA. The inhibitory activity of IFN-? was linked to the IRSE, as IRSE-mutant HBV transcribed less pgRNA and could not be repressed by IFN-? treatment. Our results identify a molecular mechanism whereby IFN-? mediates epigenetic repression of HBV cccDNA transcriptional activity, which may assist in the development of novel effective therapeutics.

AB - HBV infection remains a leading cause of death worldwide. IFN-? inhibits viral replication in vitro and in vivo, and pegylated IFN-? is a commonly administered treatment for individuals infected with HBV. The HBV genome contains a typical IFN-stimulated response element (ISRE), but the molecular mechanisms by which IFN-? suppresses HBV replication have not been established in relevant experimental systems. Here, we show that IFN-? inhibits HBV replication by decreasing the transcription of pregenomic RNA (pgRNA) and subgenomic RNA from the HBV covalently closed circular DNA (cccDNA) minichromosome, both in cultured cells in which HBV is replicating and in mice whose livers have been repopulated with human hepatocytes and infected with HBV. Administration of IFN-? resulted in cccDNA-bound histone hypoacetylation as well as active recruitment to the cccDNA of transcriptional corepressors. IFN-? treatment also reduced binding of the STAT1 and STAT2 transcription factors to active cccDNA. The inhibitory activity of IFN-? was linked to the IRSE, as IRSE-mutant HBV transcribed less pgRNA and could not be repressed by IFN-? treatment. Our results identify a molecular mechanism whereby IFN-? mediates epigenetic repression of HBV cccDNA transcriptional activity, which may assist in the development of novel effective therapeutics.

KW - Animals

KW - Humans

KW - Mice

KW - Mice, Transgenic

KW - Cell Culture Techniques

KW - Mice, SCID

KW - Virus Replication

KW - Transcription, Genetic

KW - Chimerism

KW - DNA, Circular/genetics/metabolism

KW - Epigenesis, Genetic

KW - Hepatitis B virus/genetics/metabolism

KW - Interferon-alpha/metabolism

KW - Animals

KW - Humans

KW - Mice

KW - Mice, Transgenic

KW - Cell Culture Techniques

KW - Mice, SCID

KW - Virus Replication

KW - Transcription, Genetic

KW - Chimerism

KW - DNA, Circular/genetics/metabolism

KW - Epigenesis, Genetic

KW - Hepatitis B virus/genetics/metabolism

KW - Interferon-alpha/metabolism

M3 - SCORING: Journal article

VL - 122

SP - 529

EP - 537

JO - J CLIN INVEST

JF - J CLIN INVEST

SN - 0021-9738

IS - 2

M1 - 2

ER -